* Definitive Healthcare Corp DH.OQ DH.O is expected
to show a
rise in quarterly revenue when it reports results on May 4.
* The Framingham Massachusetts-based company is expected to
report a 14.9% increase in revenue to $57.579 million from
$50.12 million a year ago, according to the mean estimate from
13 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Definitive
Healthcare
Corp is for earnings of 4 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 7
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 2.0%
in the last three months.
* Wall Street's median 12-month price target for Definitive
Healthcare Corp is $15, above its last closing price
of $10.01.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.04 0.04 0.07 Beat 67.7
Sep. 30 2022 0.05 0.05 0.06 Beat 27.7
Jun. 30 2022 0.05 0.05 0.06 Beat 18.3
Mar. 31 2022 0.03 0.03 0.05 Beat 44.9
Dec. 0.04 0.04 0.04 Met -7.4
31 2021
Sep. 30 2021 0.02 0.02 0.01 Missed -47.4
This summary was machine generated May 3 at 02:07 GMT. All
figures in US dollars unless otherwise stated